Round-up of SAFC's Glasgow conference

This content item was originally published on www.biopharma-reporter.com, a William Reed online publication.

By Natalie morrison

- Last updated on GMT

SAFC will extend its focus on high potency production through a number of new investments.

The company – who recently expanded its potent API capabilities at its plant in Jerusalem, Israel – announced its plans for further expansion in the sector during its conference at its liquid media facility in Glasgow.

Members of the biopharma and chemicals company also delivered talks on the changing nature of biosimilars and biobetters in the industry and how companies can benefit from it.

In-pharmatechnologist caught up with SAFC’s VP, global sales, Archie Cullen, as well as Grant Boldt, director of European business development, for the latest news.

QC manager for the firm’s Irvine facility, Susan Longhorn, also spoke about the companies four key areas for quality management, as well as working with regulatory agencies in today’s market.

Related news

Show more

Related product

Understanding the hidden value of quality

Understanding the hidden value of quality

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.

Follow us